Validation of a vitamin D replacement strategy in vitamin D-insufficient patients with lymphoma or chronic lymphocytic leukemia.

J G Sfeir, M T Drake, B R LaPlant, M J Maurer, B K Link, T J Berndt, T D Shanafelt, J R Cerhan, T M Habermann, A L Feldman, T Witzig

Journal: Blood cancer journal 2018;7(2):e526

PMID: 28157213

Free Full Text on Nature Publishing Group View on PubMed

Abstract

Address: Division of Endocrinology, Diabetes, Metabolism and Nutrition Department of Internal Medicine Mayo Clinic, Rochester, MN, USA.; Division of Biomedical Statistics and Informatics Mayo Clinic, Rochester, MN, USA.; Holden Comprehensive Cancer Center University of Iowa, Iowa City, IA, USA.; Mayo Clinic Health Science Research, Rochester, MN, USA.; Mayo Clinic Cancer Center Mayo Clinic, Rochester, MN, USA.; Department of Laboratory Medicine and Pathology Mayo Clinic, Rochester, MN, USA.

DOI: 10.1038/bcj.2017.9

Link outs

Free resources

Full Text Sources:

Medical:

https://medlineplus.gov/vitaminddeficiency.html

Other Literature Sources:

https://scite.ai/reports/28157213

MeSH Terms: Cholecalciferol, Humans, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Vitamin D Deficiency